PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2016 | 19 | 3 |

Tytuł artykułu

Relevance of molecular changes in the ND4 gene in German Shepherd dog tumours

Treść / Zawartość

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The aim of the study was to identify polymorphisms and mutations in the mitochondrial ND4 gene and to analyse the associations between the occurrence of molecular changes in mtDNA and phenotypic traits in tumours in German Shepherd dogs. Fifty samples obtained from blood and tumour tissues of German Shepherd dogs with diagnosed tumours were analysed. DNA extraction, amplification, and sequencing of the mtDNA ND4 gene, and bioinformatics, statistical, and in silico protein coding SNP analyses were performed. ND4 mutations and/or polymorphisms were noted in eleven nucleotide positions in nearly half of the examined dogs. All the changes were substitution mutations. A majority of the changes identified were homoplasmic. In one dog with osteosarcoma, blood heteroplasmy was detected. In two positions of the ND4 gene, presence of non-synonymous mutations leading to amino acid changes in the ND4 protein was reported. Analyses carried out to determine the deleterious effect of mutations indicated an almost 97 and 62% probability that a single amino acid substitution (p.G239V and p.I401T, respectively) in the protein has a negative impact on its function. The results of statistical analyses indicate a significant association between the occurrence of mutations in three loci of the ND4 gene and the location of tumours. The mutations identified may be a result of cell adaptation to the changes in the environment occurring during carcinogenesis. The high frequency of mutations in the tumours may indicate genetic instability of mtDNA, which may also play a role in carcinogenesis.

Słowa kluczowe

Wydawca

-

Rocznik

Tom

19

Numer

3

Opis fizyczny

p.461-469,fig.,ref.

Twórcy

autor
  • Department of Biological Bases of Animal Production, Faculty of Animal Breeding and Biology University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland
  • Department of Oncology, Medical University of Lublin, Jaczewskiego 7, 20-090 Lublin, Poland
  • Department of Genomics and Molecular Biology, National Research Institute of Animal Production, Krakowska 1, 32-083 Balice, Poland
autor
  • Department of Genomics and Molecular Biology, National Research Institute of Animal Production, Krakowska 1, 32-083 Balice, Poland
autor
  • Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland
autor
  • Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland
autor
  • Independent Medical Biology Unit, Medical University of Lublin, Jaczewskiego 8b, 20-093 Lublin, Poland

Bibliografia

  • Abu-Amero KK, Bosley TM (2006) Mitochondrial abnormalities in patients with LHON-like optic neuropathies. Invest Ophthalmol Vis Sci 47: 4211-4220.
  • Abu-Amero KK, Alzahrani AS, Zou M, Shi Y (2005) High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24: 1455-1460.
  • Bertagnolli AC, Sores P, van Asch B, Amorim A, Cirnes L, Maximo V, Cassali GD (2009) An assessment of the clonality of the components of canine mixed mammary tumors by mitochondrial DNA analysis. Vet J 182: 269-274.
  • Bianchi NO, Bianchi MS, Richard SM (2001) Mitochondrial genome instability in human cancers. Mutat Res 488: 9-23.
  • Brandon M, Baldi P, Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25: 4647-4662.
  • Davis BW, Ostrander EA (2014) Domestic dogs and cancer research: a breed-based genomics approach. ILAR J 55: 59-68.
  • Dobson JM (2013) Breed-Predispositions to Cancer in Pedigree Dogs. ISRN Vet Sci 2013: 941275.
  • Grzybowska-Szatkowska L, Slaska B (2012a) Mitochondrial DNA and carcinogenesis (review). Mol Med Rep 6: 923-930.
  • Grzybowska-Szatkowska L, Slaska B (2012b) Polymorphisms in genes encoding mt-tRNA in female breast cancer in Poland. Mitochondrial DNA 23: 106-111.
  • Grzybowska-Szatkowska L, Slaska B (2014) Mitochondrial NADH dehydrogenase polymorphisms are associated with breast cancer in Poland. J Appl Genet 55: 173-181.
  • Grzybowska-Szatkowska L, Slaska B, Rzymowska J, Brzozowska A, Floriańczyk B (2014) Novel mitochondrial mutations in the ATP6 and ATP8 genes in patients with breast cancer. Mol Med Rep 10: 1772-1778.
  • Jasik A, Reichert M (2009) Epidemiological analysis of canine skin tumors. Med Weter 65: 848-853.
  • Jónasdóttir TJ, Mellersh CS, Moe, Heggebø R, Gamlem H, Ostrander EA, Lingaas F (2000) Genetic mapping of a naturally occurring hereditary renal cancer syndrome in dogs. Proc Natl Acad Sci USA 97: 4132-4137.
  • Kaldrymidou H, Leontides L, Koutinas AF, Saridomichelakis MN, Karayannopoulou M (2002) Prevalence, Distribution and Factors Associated with the Presence and the Potential for Malignancy of Cutaneous Neoplasms in 174 Dogs Admitted to a Clinic in Northern Greece. J Vet Med A 49: 87-91.
  • Kim KS, Lee SE, Jeong HW, Ha JH (1998) The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Mol Phylogenet Evol 10: 210-220.
  • Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, CalcagnoAM, AmbudkarSV, Gottesman MM (2007) A „silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315: 525-528.
  • Lu J, Sharma LK, Bai Y (2009) Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19: 802-815.
  • Mendoza S, Konishi T, Dernell WS, Withrow SJ, Miller CW (1997) Status of the p53, Rb and MDM2 genes in canine osteosarcoma. Anticancer Res 18: 4449-4453.
  • Moe L, Gamlem H, Jonasdottir TJ, Lingaas F (2000) Renal Microcystic Tubular Lesions in Two 1Year-old Dogs-An Early Sign of Hereditary Renal Cystadenocarcinoma? J Comp Pathol 123: 218-221.
  • Murgia C, Pritchard JK, Kim SY, Fassati A, Weiss RA (2006) Clonal Origin and Evolution of a Transmissible Cancer. Cell 126: 477-487.
  • Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L (2006) Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314: 1930-1933.
  • Parmley JL, Hurst LD (2007) How do synonymous mutations affect fitness? Bioessays 29: 515-519.
  • Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, Gabrielson E, Cuomo C, Cohen D, Pandit S, Spencer M, Rabitti C, Fazio VM, Sidransky D (2001) Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61: 7623-7626.
  • Peterson MR, Frommelt RA, Dunn DG (2000) A Study of the Lifetime Occurrence of Neoplasia and Breed Differences in a Cohort of German Shepherd Dogs and Belgian Malinois Military Working Dogs that Died in 1992. J Vet Intern Med 14: 140-145.
  • Porcelli AM, Ghelli A, Ceccarelli, Lang M, Cenacchi G, Capristo M, Pennisi LF, Morra I, Ciccarelli E, Melcarne A, Bartoletti-Stella A, Salfi N, Tallini G, Martinuzzi A, Carelli V, Attimonelli M, Rugolo M, Romeo G, Gasparre G (2010) The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization. Hum Mol Genet 19: 1019-1032.
  • Salas Y, Márquez A, Diaz D, Romero L (2015) Epidemiological Study of Mammary Tumors in Female Dogs Diagnosed during the Period 2002-2012: A Growing Animal Health Problem. PLoS One 10: e0127381.
  • Slaska B, Grzybowska-Szatkowska L (2011) Analysis of the mitochondrial haplogroups of farm and wild-living raccoon dogs in Poland. Mitochondrial DNA 22: 105-110.
  • Slaska B, Grzybowska-Szatkowska L, Nisztuk S, Surdyka M, Rozanska D (2015) Mitochondrial DNA polymorphism in genes encoding ND1, COI and CYTB in canine malignant cancers. Mitochondrial DNA 26: 452-458.
  • Slaska B, Grzybowska-Szatkowska L, Surdyka M, Nisztuk, S, Rozanska D, Rozanski P, Smiech A, Orzelski M (2014) Mitochondrial D-loop mutations and polymorphisms are connected with canine malignant cancers. Mitochondrial DNA 25: 238-243.
  • Surdyka M, Slaska B (2016a) Defect of the mitochondrial DNA hypervariable region as a risk factor for canine mammary tumour. Vet Comp Oncol DOI:10.1111/vco.12224.
  • Surdyka M, Slaska B (2016b). Defect in ND2, COX2, ATP6, and COX3 mitochondrial genes as a risk factor for canine mammary tumour. Vet Comp Oncol DOI: 10.1111/vco.12247
  • Ślaska B, Grzybowska-Szatkowska L, Bugno-Poniewierska M, Surdyka M, Śmiech A (2013) Nuclear and mitochondrial DNA mutation in human and canine tumors. Med Weter 69: 195-202.
  • Ślaska B, Surdyka M, Brodzki A, Nisztuk S, Gurgul A, Bugno-Poniewierska M, Śmiech A, Różańska D, Orzelski M (2014) Mitochondrial D-loop mutations can be detected in sporadic malignant tumours in dogs. Bull Vet Inst Pulawy 58: 631-637.
  • Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30: 2725-2729.
  • Treggiari E, Pedro B, Dukes-McEwan J, Gelzer AR, Blackwood L (2015) A descriptive review of cardiac tumours in dogs and cats. Vet Comp Oncol DOI: 10.1111/vco.12167.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-dd74d700-9f6e-42e3-9320-1a0c5351755f
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.